International law firm Ashurst is advising NetScientific plc ("NetScientific") on its strategic review announced Monday pursuant to which the board of NetScientific has decided to conduct a review of the various strategic options open to it, one of which is a sale of NetScientific.  Accordingly, the strategic review includes a formal sale process to be conducted under the regime set out in the UK Takeover Code.

NetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases.

The Ashurst team is being led by corporate partners James Fletcher and Tara Waters, assisted by associates Harry Thimont and Viktoria Grohmann.